Cholesterol & Lipid
Sort by:
University of Louisville
New Advances in Dyslipidemias
FEATURING
Dinesh Kalra
- 1,008 views
- January 5, 2023
- 13
Norman Lepor
Remnant Lipoproteins: The Rediscovered CVD Risk Factor - Are We Missing the Target?
- 1,758 views
- December 20, 2022
- 9
The North American Thrombosis Forum (NATF)
Identifying Patients Who Would Benefit from PCSK9 Inhibitors
- 461 views
- January 26, 2023
- 1
Houston Methodist DeBakey Heart and Vascular Center
Early Metabolic Derangements: Time to Intervene Prior to Overt Obesity
FEATURING
Arthur Agatston
- 191 views
- November 15, 2022
Houston Methodist DeBakey Heart and Vascular Center
Cross Talk Between Obesity, Fatty Liver and Metabolic Syndrome
FEATURING
David W. Victor III
- 690 views
- November 15, 2022
- 8
Top Ten Topics in Clinical Cardiology 2022
What’ll be New in Lipid Management in 2023? Rethinking the Paradigms
FEATURING
Robert Rosenson
- 3,191 views
- November 21, 2022
- 10
The North American Thrombosis Forum (NATF)
The Critical Importance of Lowering LDL-C in High-Risk Patients
- 420 views
- January 26, 2023
- 3
Michigan Medicine
Supplements for Heart Patients
FEATURING
Michael Shea
- 895 views
- September 28, 2022
- 5
Metabolic Health Summit
Lipid Management & Low Carb Diets
FEATURING
Bret Scher
- 3,778 views
- July 1, 2022
- 27
Canadian Collaborative Research Network
Cardiovascular Risk Reduction: More Than Just LDL-Cholesterol
FEATURING
Deepak Bhatt
- 1,194 views
- June 13, 2022
- 13
Georgia Heart Institute
Interview with Dr. Nehal Mehta, CCTA is the Future of Coronary Risk Stratification
FEATURING
Nehal N. Mehta
- 451 views
- June 21, 2022
- 4
Houston Methodist Hospital
Targeting Cardiometabolic Health In Our Community
FEATURING
Khurram Nasir
- 291 views
- March 22, 2022
- 2
Scripps Health
Heart Disease Prevention and Early Detection
FEATURING
Christina Adams
- 930 views
- May 6, 2022
- 5
Cleveland Clinic Endocrinology & Metabolism Institute
Update on the Management of Hypercholesterolemia
FEATURING
Barbara Carranza Leon
- 1,004 views
- January 27, 2022
- 6
AHA 2022 Conference Coverage
AHA 2022: Emerging RNA Therapeutics for Lowering Serum LP(a)
FEATURING
Peter Toth
- 951 views
- November 14, 2022
- 3
Houston Methodist DeBakey Heart and Vascular Center
Debate: CCTA and FFR-CT Should Be the First Choice in the Assessment of Suspected CAD: Pro
FEATURING
Jonathon Leipsic
- 643 views
- January 5, 2022
- 11
Advances in Cardiovascular Disease Prevention
Lifestyle Management to Reduce Cardiovascular Risk
FEATURING
Andrew Freeman
- 1,562 views
- October 22, 2018
- 9
Houston Methodist DeBakey Heart and Vascular Center
CVD Prevention Considerations Among Those With Low Testosterone
FEATURING
Matthew Budoff
- 486 views
- October 20, 2021
- 5